CRH Medical Corp Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017
Cash and cash equivalents
Trade and other receivables
Prepaid expenses and deposits
Inventories
Total current assets
Property and equipment
Intangible assets
Deferred tax assets
Total non-current assets
Assets
Trade and other payables
Employee benefits
Current tax liabilities
Notes payable and bank indebtedness
Deferred consideration
Loan
Total current liabilities
Earn-out obligation
Total non-current liabilities
Share capital
Contributed surplus
Accumulated other comprehensive income loss
Retained earnings
Total equity attributable to shareholders of the Company
Equity
Assets
Current assets:
Cash and cash equivalents
Trade and other receivables, net
Income tax receivable
Prepaid expenses and deposits
Loan to equity investee
Inventories
Total current assets
Non-current assets:
Property and equipment, net
Right of use assets
Intangible assets, net
Deferred asset acquisition costs
Equity accounted investment
Investment
Equity investment
Deferred tax assets
Total non-current assets
Total assets
Current liabilities:
Trade and other payables
Employee benefits
Income tax payable
Current obligation related to right of use assets
Current portion of lease liability
Current tax payable
Notes payable and bank indebtedness
Deferred consideration
Earn-out obligation
Short-term advances
Contract payable - CMS Advancement
Member loan
Total current liabilities
Non-current liabilities:
Deferred consideration
Long-term obligation related to right of use assets
Contingent consideration
Lease liability
Contract payable - CMS Advance
Notes payable and bank indebtedness
Earn-out obligation
Deferred tax liabilities
Total non-current liabilities

Equity
Common stock, no par value; 71,674,647 and 71,603,584 shares issued and outstanding at December 31, 2020 and 2019, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings (loss)
Total equity attributable to shareholders of the Company
Non-controlling interest
Total equity
Total liabilities and equity

Comments